BioMarin Pharmaceutical I... (BMRN)
62.15
-1.66 (-2.60%)
At close: Jan 15, 2025, 11:39 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
| Net Income | 167.65M | 141.56M | -64.08M | 859.10M | -23.85M | -77.21M | -117.04M | -630.21M | -171.80M | -133.97M | -176.35M | -114.35M | -53.84M | 205.82M | -488.00K | 30.83M | -15.80M | -28.53M | -74.27M | -187.44M | -76.38M | -77.37M | -57.43M | -37.36M | -28.07M | -12.30M |
| Depreciation & Amortization | 104.39M | 101.97M | 108.04M | 105.17M | 105.30M | 95.67M | 87.86M | 96.91M | 47.19M | 56.74M | 47.26M | 45.30M | 36.09M | 27.74M | 20.98M | 17.63M | 1.09M | 11.96M | 10.07M | 13.28M | 9.44M | 8.50M | 7.00M | 7.33M | 6.56M | 800.00K |
| Stock-Based Compensation | 207.10M | 196.31M | 197.26M | 189.71M | 159.87M | 148.82M | 140.26M | 134.64M | 111.53M | 88.23M | 66.18M | 47.34M | 43.91M | 38.36M | 36.01M | 28.34M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Working Capital | -57.90M | -5.10M | -15.65B | -35.52M | -5.77M | 7.98M | 3.35M | -10.39M | -2.41M | -3.34M | 11.23M | 1.96M | 1.13M | -3.43M | 36.59M | -2.10M | -5.84M | -15.35M | 16.09M | 4.26M | -6.31M | -1.97M | -2.70M | 469.00K | 1.61M | 900.00K |
| Other Non-Cash Items | 61.65M | -115.47M | 12.89M | 44.71M | -9.20M | -29.27M | -70.34M | 559.15M | -178.11M | -28.72M | 35.51M | 16.18M | 13.32M | 19.50M | 2.04M | -15.00K | -6.57M | -3.99M | -5.99M | 104.76M | -1.56M | 17.24M | 30.06M | 16.43M | 6.97M | 2.60M |
| Deferred Income Tax | -44.98M | -52.09M | -15.61M | -888.91M | -82.76M | -68.38M | 44.46M | -228.05M | -76.83M | -25.48M | -9.16M | -9.92M | 4.36M | -230.58M | 9.32M | 3.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -336.54M | -96.38M | 66.03M | -224.42M | -101.09M | -49.42M | -93.96M | -160.28M | 46.33M | -30.34M | -23.08M | 33.06M | -25.10M | -42.09M | 19.87M | -88.99M | -13.21M | -29.52M | 7.50M | 4.26M | -6.31M | -1.97M | -2.70M | 709.00K | 1.60M | 800.00K |
| Operating Cash Flow | 159.26M | 175.90M | 304.54M | 85.36M | 48.26M | 20.21M | -8.76M | -227.84M | -221.69M | -73.54M | -59.63M | 17.61M | 18.75M | 18.75M | 87.73M | -9.18M | -34.49M | -50.09M | -62.68M | -65.14M | -74.80M | -53.59M | -23.07M | -12.90M | -12.94M | -8.10M |
| Capital Expenditures | -107.61M | -131.54M | -119.22M | -137.52M | -163.41M | -144.62M | -199.22M | -148.38M | -227.65M | -118.83M | -65.12M | -44.57M | -154.22M | -49.46M | -89.80M | -56.37M | -22.41M | -24.58M | -2.96M | -24.07M | -5.97M | -4.86M | -17.81M | -3.76M | -22.94M | -6.40M |
| Acquisitions | n/a | n/a | -23.65M | -23.21M | 6.62M | 50.00M | 125.00M | -2.79M | -910.15M | -1.10M | -10.76M | -1.74M | 81.00M | -32.95M | -8.37M | n/a | n/a | n/a | n/a | -14.79M | n/a | -3.12M | n/a | n/a | -1.50M | n/a |
| Purchase of Investments | -868.50M | -611.81M | -937.14M | -538.37M | -632.02M | -634.75M | -655.45M | -699.75M | -876.51M | -559.32M | -395.04M | -387.17M | -217.33M | -225.29M | -439.30M | -740.57M | -838.86M | -219.89M | n/a | -37.44M | -125.08M | n/a | -94.90M | -13.70M | -37.60M | -1.10M |
| Sales Maturities Of Investments | 864.86M | 620.00M | 691.05M | 555.83M | 740.21M | 993.73M | 425.96M | 367.57M | 424.71M | 808.31M | 288.64M | 237.84M | 281.99M | 206.36M | 475.31M | 777.86M | 693.81M | 29.91M | 26.38M | 86.31M | 80.07M | 78.62M | n/a | 15.90M | n/a | n/a |
| Other Investing Acitivies | -10.92M | 103.33M | 22.65M | 89.64M | 17.57M | -10.00K | -1.75M | -698.00K | 410.00M | 65.50M | -116.50M | -151.07M | -81.00M | n/a | -17.52M | n/a | 16.47M | 19.80M | 34.18M | -25.30M | 28.00K | 272.00K | -21.20M | n/a | -6.71M | -700.00K |
| Investing Cash Flow | -111.24M | -20.03M | -366.31M | -53.62M | -31.03M | 264.35M | -305.46M | -484.05M | -1.18B | 194.56M | -298.78M | -195.65M | -89.56M | -101.34M | -79.67M | -19.08M | -151.00M | -194.77M | 57.60M | -15.29M | -50.95M | 70.91M | -133.91M | -1.55M | -68.75M | -8.20M |
| Debt Repayment | -2.29M | -2.60M | -3.04M | 203.84M | -5.09M | -374.95M | 481.69M | n/a | n/a | n/a | 713.24M | n/a | -879.00K | -195.00K | -74.78M | -94.00K | 309.35M | 163.12M | 177.00K | 293.00K | 118.40M | 214.00K | 5.26M | 776.00K | 25.59M | 100.00K |
| Common Stock Repurchased | n/a | -54.28M | -45.80M | -50.00M | -42.68M | -35.92M | -33.51M | n/a | n/a | n/a | -6.40M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -85.79M | -16.05M | 2.99M | 27.27M | -69.59M | -13.05M | 25.46M | 14.17M | 39.66M | 68.90M | 33.43M | 76.79M | -3.38M | 3.70M | 11.00M | 22.90M | n/a | -7.70M | 22.13M | -30.00M | 485.00K | 1.75M | 13.16M | n/a | n/a | -100.00K |
| Financial Cash Flow | -18.73M | -18.65M | -48.00K | 181.12M | -74.67M | -388.01M | 507.14M | 727.11M | 927.91M | 185.69M | 746.67M | 312.29M | 29.00M | 3.50M | -63.79M | 22.81M | 324.57M | 295.94M | 30.09M | -27.89M | 213.47M | 3.85M | 152.99M | 7.57M | 95.69M | 19.70M |
| Net Cash Flow | 30.60M | 137.25M | -61.88M | 211.71M | -56.54M | -104.05M | 189.70M | 11.29M | -478.45M | 306.70M | 388.25M | 134.25M | -41.81M | -79.09M | -55.73M | -5.44M | 139.18M | 51.07M | 25.01M | -108.33M | 87.77M | 21.11M | -4.00M | -6.88M | 14.00M | 3.40M |
| Free Cash Flow | 51.65M | 44.36M | 185.31M | -52.15M | -115.14M | -124.41M | -207.98M | -376.22M | -449.34M | -192.37M | -124.76M | -26.96M | -135.47M | -30.71M | -2.07M | -65.54M | -56.91M | -74.67M | -65.64M | -89.22M | -80.77M | -58.46M | -40.88M | -16.66M | -35.88M | -14.50M |